Market Overview:
The global glycated hemoglobin testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of diabetes, growing awareness about diabetes and its complications, and technological advancements in glycated hemoglobin testing devices. The global glycated hemoglobin testing market is segmented on the basis of type into lab-based test and point-of-care test. The lab-based test segment is further subsegmented into immunoturbidimetric assay, enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, boronate affinity chromatography assay, and others. The point-of-care test segment is further subsegmented into glucose oxidase method (GOD/POD) method and reflectance photometry method (RPM). On the basis of application, the global glycated hemoglobin testing market is divided into hospitals, clinics, diagnostic laboratories, academic and research institutes.
Product Definition:
A glycated hemoglobin test measures the percentage of hemoglobin in your blood that is glycosylated. Hemoglobin is a protein inside red blood cells that carries oxygen throughout your body. When glucose (sugar) levels are high, more sugar attaches to hemoglobin, resulting in a higher glycated hemoglobin level. The higher the level, the greater your risk of developing diabetes-related complications such as heart disease, eye problems, and kidney disease.
Lab Based Test:
A lab-based test is a method of determining blood sugar levels that involves analyzing the level of sugar in the blood after an interval of time. The most common type of tests used by people are called glycated hemoglobin (A1C) tests. These tests are also known as glucose tolerance or diabetes testing because they help detect whether or not a patient has been given too much insulin, which can cause diabetes.
Point-of-Care Test:
Point-of-care (POC) tests are medical devices used in the examination of a patient's health at the time of care. These tests aid healthcare professionals to make an accurate diagnosis and provide appropriate treatment. POC testing is gaining popularity due to its ease, speed, cost effectiveness, portability & immediate results as compared to conventional laboratory testing procedures.
Application Insights:
On the basis of application, the global glycated hemoglobin testing market is segmented into hospitals, clinics, diagnostic laboratories, academic and research institutes and others. Hospitals held the largest share in 2017 due to presence of a large number of patients suffering from chronic diseases such as heart diseases & stroke. Thus there is an increased demand for glycated hemoglobin testing kits in these institutions.
Clinical diagnosis involves detection of disease at its initial stage when it has just begun to develop or before it has been diagnosed by laboratory tests or imaging techniques.
Regional Analysis:
North America accounted for the largest revenue share in 2017 owing to the presence of a large number of Glyco- testing laboratories and an increase in demand for advanced diagnostic tests. The region is expected to maintain its dominance during the forecast period due to increasing awareness about G6PD deficiency, growth in diabetes population, and rise in healthcare expenditure.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income especially after tax which most people prefer spending on health care goods and services rather than on food or medical treatments. This has resulted into growing adoption of glycated hemoglobin testing products by hospitals as well as clinics across this region thereby driving market growth. Moreover, government initiatives such as “Hospital Efficient Diagnosis†program are also expected fuel regional market development during the forecast period (2016-2030).
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. According to the World Health Organization (WHO), the number of people with diabetes has quadrupled since 1980 and as of 2014, there were 422 million people living with diabetes. This number is expected to reach 642 million by 2040. The high incidence of diabetes is a major driver for the growth of the glycated hemoglobin testing market.
- Rising awareness about glycemic control: There is a growing awareness among patients and healthcare professionals about the importance of glycemic control in preventing long-term complications associated with diabetes such as heart disease, stroke, kidney failure, and blindness. This is driving demand for glycated hemoglobin testing products and services worldwide.
- Technological advancements: The development of novel technologies such as point-of-care (POC) tests has helped to make glycated hemoglobin testing more accessible and affordable for patients worldwide. POC tests are easy to use and can be performed in minutes, making them ideal for use in clinics, hospitals, pharmacies, and other settings where rapid results are required..
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycated Hemoglobin Testing Market Research Report
By Type
Lab Based Test, Point-of-Care Test
By Application
Hospitals, Clinics, Diagnostic Laboratories, Academic and Research Institutes
By Companies
Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Glycated Hemoglobin Testing Market Report Segments:
The global Glycated Hemoglobin Testing market is segmented on the basis of:
Types
Lab Based Test, Point-of-Care Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Laboratories, Academic and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Bio-Rad Laboratories
- Danaher
- EKF Diagnostics
- F. Hoffmann-La Roche
Highlights of The Glycated Hemoglobin Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lab Based Test
- Point-of-Care Test
- By Application:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycated Hemoglobin Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycated hemoglobin (HbA1c) is a blood test that measures the average amount of glucose in your blood over the past two to three months. Glucose levels can increase as we age, and may be a sign of diabetes or other health problems. High HbA1c levels may indicate that you are having more trouble controlling your blood sugar levels than usual.
Some of the key players operating in the glycated hemoglobin testing market are Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche.
The glycated hemoglobin testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glycated Hemoglobin Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glycated Hemoglobin Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glycated Hemoglobin Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glycated Hemoglobin Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glycated Hemoglobin Testing Market Size & Forecast, 2018-2028
4.5.1 Glycated Hemoglobin Testing Market Size and Y-o-Y Growth
4.5.2 Glycated Hemoglobin Testing Market Absolute $ Opportunity
Chapter 5 Global Glycated Hemoglobin Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glycated Hemoglobin Testing Market Size Forecast by Type
5.2.1 Lab Based Test
5.2.2 Point-of-Care Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glycated Hemoglobin Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glycated Hemoglobin Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Academic and Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glycated Hemoglobin Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glycated Hemoglobin Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glycated Hemoglobin Testing Analysis and Forecast
9.1 Introduction
9.2 North America Glycated Hemoglobin Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glycated Hemoglobin Testing Market Size Forecast by Type
9.6.1 Lab Based Test
9.6.2 Point-of-Care Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glycated Hemoglobin Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Laboratories
9.10.4 Academic and Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glycated Hemoglobin Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Glycated Hemoglobin Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glycated Hemoglobin Testing Market Size Forecast by Type
10.6.1 Lab Based Test
10.6.2 Point-of-Care Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glycated Hemoglobin Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Laboratories
10.10.4 Academic and Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glycated Hemoglobin Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glycated Hemoglobin Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glycated Hemoglobin Testing Market Size Forecast by Type
11.6.1 Lab Based Test
11.6.2 Point-of-Care Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glycated Hemoglobin Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Laboratories
11.10.4 Academic and Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glycated Hemoglobin Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Glycated Hemoglobin Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glycated Hemoglobin Testing Market Size Forecast by Type
12.6.1 Lab Based Test
12.6.2 Point-of-Care Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glycated Hemoglobin Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Laboratories
12.10.4 Academic and Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glycated Hemoglobin Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glycated Hemoglobin Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glycated Hemoglobin Testing Market Size Forecast by Type
13.6.1 Lab Based Test
13.6.2 Point-of-Care Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glycated Hemoglobin Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Laboratories
13.10.4 Academic and Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glycated Hemoglobin Testing Market: Competitive Dashboard
14.2 Global Glycated Hemoglobin Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Bio-Rad Laboratories
14.3.3 Danaher
14.3.4 EKF Diagnostics
14.3.5 F. Hoffmann-La Roche
